From the Editors

What to expect in this month's issue of The Oncology Nurse APN/PA
Here's what to expect from the February issue of The Oncology Pharmacist.
The January issue of The Oncology Nurse-APN/PA (TON) is full of important news and updates for oncology nurses
Here's what you can expect to see in this month's issue of The Oncology Nurse APN/PA.

In the October issue of The Oncology Pharmacist, we feature highlights from the recent Hematology/Oncol­ogy Pharmacy Association (HOPA)’s Oncology Pharmacy Practice Man­agement Program, including an article on the challenges of managing patients with non–small-cell lung cancer (NSCLC) associated with ALK mutations. At HOPA, Jim M. Koeller, MS, Professor, College of Pharmacy, The University of Texas at Austin, discussed the current treatment guidelines for this patient population, emphasizing the need for pharmacist inclusion during testing for ALK mutations.

As always, we hope you will enjoy this issue of TON and look forward to receiving your feedback.

In this issue of The Oncology Pharmacist, we feature an article on the new—and often misunderstood—world of biosimilars
We hope you enjoy this issue, and sincerely look forward to receiving your feedback.
We hope you enjoy this issue, and sincerely look forward to receiving your feedback.
In the May issue of The Oncology Pharmacist, we feature a recent study that was presented at the 2016 Multidisciplinary Head and Neck Cancer Symposium on the association between prophylactic gabapentin, weight loss, and narcotic dependency in patients with oropharyngeal cancer undergoing radiation therapy.
Page 1 of 6
Results 1 - 10 of 52